ArticleMolecular cancer therapeutics2026

A whole genomic CRISPR-Cas9 screen identifies the amino acid transporter SLC43A1 (LAT3) as a major determinant of oxaliplatin sensitivity in colorectal cancer cells.

Nisha R Pawar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.